βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22958921.
- Also identified by DOI 10.1016/j.cmet.2012.08.002 and PMC identifier 3447537.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fibroblast growth factor 21 (FGF21) is a fasting-induced hepatokine that has potent pharmacologic effects in mice, which include improving insulin sensitivity and blunting growth. The single-transmembrane protein βKlotho functions as a coreceptor for FGF21 in vitro. To determine if βKlotho is required for FGF21 action in vivo, we generated whole-body and adipose tissue-selective βKlotho-knockout mice. All of the effects of FGF21 on growth and metabolism were lost in whole-body βKlotho-knockout mice. Selective elimination of βKlotho in adipose tissue blocked the acute insulin-sensitizing effects of FGF21. Taken together, these data demonstrate that βKlotho is essential for FGF21 activity and that βKlotho in adipose tissue contributes to the beneficial metabolic actions of FGF21.
Medical subject headings
- Adipose Tissue
- Energy Metabolism
- Fibroblast Growth Factors
- Growth
- Insulin Resistance
- Membrane Proteins